Screening the genome for HCC-specific CpG methylation signatures as biomarkers for diagnosis and prognosis evaluation
Abstract Background Hepatocellular carcinoma (HCC) is one of the most common and invasive malignant tumors in the world. The change in DNA methylation is a key event in HCC. Methods Methylation datasets for HCC and 17 other types of cancer were downloaded from The Cancer Genome Atlas (TCGA). The CpG...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-06-01
|
| Series: | BMC Medical Genomics |
| Online Access: | https://doi.org/10.1186/s12920-021-01015-9 |